Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × sodium thiosulfate × Gastrointestinal × Clear all

Status

Sponsor Class

Study Type

Interventional 8 Expanded_access 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hepatoblastoma 1 Hearing Loss 1

Interventions

regorafenib 2 Sunitinib 2 zenocutuzumab 1 ulixertinib 1 sodium thiosulfate 1 selpercatinib 1 ripretinib 1 peginterferon alfa-2a 1 pegilodecakin 1 onvansertib 1 omburtamab I-131 1 guselkumab 1 futibatinib 1 derazantinib 1 balstilimab 1 avapritinib 1 Tenofovir 1 Taxes 1 Ramucirumab 1 Proton Pump Inhibitors 1 Oxaliplatin 1 Melphalan 1 Leucovorin 1 Laparoscopy 1 IMM-101 1 IFL protocol 1 Hydrocortisone 1 HMPL-013 1 Gemcitabine 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04132882 2021-09-16

A Compassionate Use Program to Provide Access to Sodium Thiosulfate

TRPHARM

Gastrointestinal

Hepatoblastoma, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡